Spinal muscular atrophy is a neuromuscular disease caused by a genetic mutation that results in a lack of the survival motor neuron protein. The disease leads to degeneration of motor neurons and muscle atrophy. A potential new treatment involves using antisense oligonucleotides to modify gene splicing and increase production of the survival motor neuron protein in motor neurons. RNA structures were likely important before the evolution of DNA as some bacteria have RNA sensors that control gene expression. Discovering these ancient RNA remnants helps understand evolutionary relationships between species. Redirecting alternative splicing through antisense oligonucleotides could treat diseases caused by splicing errors like spinal muscular atrophy.